Skip to main content
Download PDF

Relationship between chorioamnionitis or funisitis and lung injury among preterm infants: meta-analysis involved 16 observational studies with 68,397 participants

BMC Pediatrics volume 24, Article number: 157 (2024) Cite this article

Abstract

Background

Chorioamnionitis (CA) can cause multiple organ injuries in premature neonates, particularly to the lungs. Different opinions exist regarding the impact of intrauterine inflammation on neonatal respiratory distress syndrome (NRDS) and bronchopulmonary dysplasia (BPD). We aim to systematically review the relationship between CA or Funisitis (FV) and lung injury among preterm infants.

Methods

We electronically searched PubMed, EMbase, the Cochrane library, CNKI, and CMB for cohort studies from their inception to March 15, 2023. Two reviewers independently screened literature, gathered data, and did NOS scale of included studies. The meta-analysis was performed using RevMan 5.3.

Results

Sixteen observational studies including 68,397 patients were collected. Meta-analysis showed CA or FV increased the lung injury risk (OR = 1.43, 95%CI: 1.06–1.92). Except for histological chorioamnionitis (HCA) (OR = 0.72, 95%CI: 0.57–0.90), neither clinical chorioamnionitis (CCA) (OR = 1.86, 95%CI: 0.93–3.72) nor FV (OR = 1.23, 95%CI: 0.48–3.15) nor HCA with FV (OR = 1.85, 95%CI: 0.15–22.63) had statistical significance in NRDS incidence. As a result of stratification by grade of HCA, HCA (II) has a significant association with decreased incidence of NRDS (OR = 0.48, 95%CI: 0.35–0.65). In terms of BPD, there is a positive correlation between BPD and CA/FV (CA: OR = 3.18, 95%CI: 1.68–6.03; FV: OR = 6.36, 95%CI: 2.45–16.52). Among CA, HCA was positively associated with BPD (OR = 2.70, 95%CI: 2.38–3.07), whereas CCA was not associated with BPD (OR = 2.77, 95%CI: 0.68–11.21). HCA and moderate to severe BPD (OR = 25.38, 95%CI: 7.13–90.32) showed a positive correlation, while mild BPD (OR = 2.29, 95%CI: 0.99–5.31) did not.

Conclusion

Currently, evidence suggests that CA or FV increases the lung injury incidence in premature infants. For different types of CA and FV, HCA can increase the incidence of BPD while decreasing the incidence of NRDS. And this “protective effect” only applies to infants under 32 weeks of age. Regarding lung injury severity, only moderate to severe cases of BPD were positively correlated with CA.

Peer Review reports

Background

Premature infants can be exposed to intrauterine infections up to 40%-70% [1, 2], of which CA is the leading cause of spontaneous preterm birth [3, 4]. An estimated 2% of pregnant women around the world are affected by CA, which refers to an infection of the amniotic fluid, placenta, or fetus caused by pathogenic bacteria [5, 6]. It is defined as the infiltration of multinucleate cells into the amniotic membrane and the chorionic membrane, and if the infection or inflammation processes involving the umbilical cord (umbilical vein, umbilical artery, and the Wharton’s jelly) are referred to as acute funisitis (FV) [7, 8]. After birth of premature infants, CA can cause multiple organ injuries, including lung, brain, gastrointestinal injuries, and the outcome is worse when combined with FV, which constitutes fetal inflammation or fetal inflammatory response syndrome [5, 9, 10]. CA has been found to be associated with a wide range of common postnatal diseases in premature infants, including respiratory distress syndrome (RDS), bronchiolar pulmonary dysplasia (BPD), intraventral hemorrhage and necrotizing enterocolitis (NEC), with the lung being the most easily affected part [11].

In premature infants, neonatal respiratory distress syndrome (NRDS) is a common respiratory condition caused by the decreased production or increased destruction of pulmonary surfactant (PS) secreted by alveolar type II epithelial cells. This condition is characterized by progressive and aggravated respiratory distress [12, 13] and is frequently associated with respiratory disease and death in newborns [14]. According to statistics, the overall prevalence rate of neonatal ARDS is 1.5%, and the overall mortality rate is as high as 17% ~ 24% [15]. Infection (both internal and external to the lung), acidosis, asphyxia [16] preterm birth, diabetic mothers, and insufficient secretion of primary PS are some of the causes of NRDS [17]. However, some studies have discovered fetal lung development can be aided by intrauterine inflammation [18,19,20].

At present, there are only three pertinent systematic reviews and meta-analyses [21,22,23] on the impact of CA and FV on lung injuries in premature infants. Some similar subjects have been conducting in China, while there are no relevant reviews and meta-analyses. Glucocorticoids possess strong anti-inflammatory properties. Early intravenous administration of glucocorticoids inhibits the inflammatory response in the lungs of extremely premature infants [24]. As a result, to improve clinical workers' attention to such premature infants and invite neonatal intensive care unit (NICU) consultation as soon as possible after birth, we still require a lot of clinical research data to further explore the relationship between CA or FV and lung injury in premature infants, thereby allowing for early intervention. As a result, it can lower disease incidence, reduce disease severity, improve the prognosis for children, and serve as a theoretical basis for reducing the burden on families and conserving social resources.

Methods

A systematic review of cohort study was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions [25]. The protocol was registered on PROSPERO, the international database of prospectively registered systematic reviews. The systematic review was reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement [26].

Search strategy

Original research on the association between chorioamnionitis or funisitis and Lung Injury among Preterm Infants was retrieved from PubMed, EMbase, the Cochrane library, CNKI and CMB, from inception to March 15, 2023. The retrieval formula for this study was as follows: ((Chorioamnionitis) OR (Chorioamnionitides) OR (Amnionitis) OR (Amnionitides) OR (Funisitis) OR (Funisitides)) AND ((Neonatal respiratory distress syndrome) OR (Infantile Respiratory Distress Syndrome) OR (Neonatal Respiratory Distress Syndrome) OR (Respiratory Distress Syndrome, Infant) OR (bronchopulmonary dysplasia) OR (Dysplasia, Bronchopulmonary) OR (Lung Injury) OR (injuries lung) OR (injury lung) OR (pulmonary injury) OR (injuries pulmonary) OR (injury pulmonary) OR (pulmonary injuries) OR (lung injuries) OR (chronic lung injury) OR (chronic lung injuries) OR (injuries chronic) OR (lung injury chronic)). Additional strategies for identifying studies included a manual review of reference lists from key articles that fulfilled our eligibility criteria as well as other systematic reviews on CA, use of the “related articles” feature in PubMed, and use of the “cited by” tool in Web of Science. No language limit was applied. Narrative reviews, systematic reviews, letters, editorials, case–control studies and commentaries were excluded but were read to identify potential additional studies.

Eligibility and excluded criteria

The following criteria were used to select studies for inclusion in the meta-analysis: (1) a population under 37 weeks of age; (2) single pregnancy; (3) exposure to CA/FV; (4) the non-exposed group is non-CA/FV (N-CCA/N-HCA/N-FV); (5) the outcome was lung injury, including RDS and BPD; (6) provide definitions of outcomes (RDS/BPD); (7) provide primary data to assess the relationship between CA/FV exposure and lung injury (RDS/BPD); (8) cohort study.

Excluded criteria: (1) the included population was not preterm infants; (2) twins or multiple pregnancies; (3) pregnancy status was not specified; (4) infants with extremely low birth weight without certainty of preterm birth; (5) the definition of the outcome indicator is not provided; (6) data missing; (7) other researches’ design such as case–control.

Data extraction

Two of us (LWL, ZY) independently screened the search results and applied inclusion criteria using a structured form to identify relevant studies. In several rounds: by the title alone in the first round, the title and abstract in the second and the full text in the third. Discrepancies were settled through discussion or consultation with a third reviewer (CSJ). Data extraction and quality assessment were carried out by two authors (LWL and ZY) and verified the accuracy and completeness of the data extraction by a second reviewer (ZC). Using a predetermined data extraction form, the following details were extracted from pertinent studies: the citation information, the country of the participants, the average gestational age and weight of each study, the study design, BPD definitions, the number of patients in each exposure group and control group, and other directly extractable data were first extracted for each study. Incidentally, classification and integration were estimated for data not reported directly.

In regard to lung injury, we research two types of diseases: NRDS and BPD. NRDS was diagnosed and graded in accordance with the Paediatric Acute Lung Injury Consensus Conference (PALICC) [27]. And BPD was diagnosed and graded according to the National Institute of Child Health and Human Development (NICHD) [28]. In addition, there are two definitions of BPD, one of which is defined as oxygen dependency at 36 weeks after menstruation (BPD36) and the other as dependency on oxygen supplementation at a corrected age of 28 days (BPD28) [28]. The diagnosis and grading criteria for CA (HCA, CCA) and FV refer to pathological diagnoses [7, 29]. All studies with the same definition were included. Studies that did not explicitly state a definition of CA (HCA/CCA) were excluded from subgroup classification.

Validity assessment

We independently read and evaluated the quality of the literature included with the Newcastle–Ottawa Scale (NOS) [30]. Each asterisk represents a point, and the total score is the sum of all the points. A total score of 7 or higher was considered high quality research. Studies were excluded if data could not be extracted or obtained by contacting the authors. Duplicate studies were also ignored.

Statistical analysis

The effect of CA or FV on lung injury was analyzed using the odds ratio (OR) and 95% confidence interval (CI) as an effect measure. Between-study heterogeneity was assessed using Cochran’s Q and I2 statistics. Initial analyses with I2 ≤ 40% was performed with a fixed-effects model, otherwise, the random effects model is adopted. The potential confounding variables included gestational age, birth weight, the severity of lung injury (BPD (mild, moderate, severe, and moderate or severe) and NRDS), maternal age, antenatal corticosteroids, and the different classification and staging of CA (HCA (I, II, and III) and CCA) were considered the primary sources of heterogeneity, and subgroup analyses were carried out. All statistical analyses were performed with RevMan 5.3. The exposure group was divided into five distinct categories: CA, HCA, CCA, FV, HCA, and FV. The funnel plot was used to evaluate bias, and a portion of the bias was determined by observing the funnel plot’s symmetry.

Results

All reference studies

We searched a total of 2,683 studies. After initial evaluation, 588 studies were removed for being duplicates, 1,925 for being irrelevant (as determined by reading the title and abstracts), and 154 studies for reasons determined by reading the full text. Ultimately, 16 studies [19, 31,32,33,34,35,36,37,38,39,40,41,42,43,44,45] (shown in Additional file 1) were identified, involving 68,397 participants. Figure 1 shows a flow diagram of the process.

Fig. 1
figure 1

Flow diagram of study selection

Full size image

Among these 16 articles, for RDS outcome in preterm infants, 11 studies [19, 31, 34,35,36,37,38, 40, 42, 43, 45] discuss HCA and its relationship, 2 [32, 39] discuss CCA and its relationship, 4 [19, 33,34,35] discuss FV and its relationship and 2 [19, 40] discuss HCA with FV and its relationship; for BPD outcome in preterm infants, 7 articles [34, 37, 38, 40, 41, 43, 44] research correlation between BPD and HCA, 2 [32, 39] discuss BPD and CCA; 6 studies [34, 38,39,40,41, 44] provided data on BPD28 and 3 studies [32, 37, 43] provided data on BPD36; 1study [44] provided data on mild and moderate to severe BPD. The number of cases in 5 studies [32, 36, 38, 39, 43] exceeds 500; for CA, we quest the influence of the classification and the stage on BPD and RDS in preterm infants. The primary characteristics of the research cited in this document are presented in Additional file 1. 154 studies were excluded from the analysis, as detailed in Additional file 2. The evaluation details and results are presented in Additional file 3. We identify 14 high-quality studies [19, 31,32,33,34,35,36,37, 39,40,41,42, 44] with a score of 7 or higher from the NOS scale. Moreover, all funnel plots are symmetrical and unbiased.

Whether CA or FV impact on lung injury in preterm infants

A total of 16 studies were enrolled on the relationship between CA or FV and lung injury, with CA (HCA, CCA), FV, HCA and FV as exposure groups, and no CA or FV as non-exposure groups. Comparing to the non-CA/FV, calculations (OR = 1.43, 95%CI: 1.06–1.92, I2 = 96%) in Table 1 and Fig. 2 demonstrated that CA or FV were associated with an increased incidence of lung injury in premature infants, particularly in developed countries (OR = 1.56, 95%CI: 1.08–2.27, I2 = 96%), and were not statistically significant in developing countries (OR = 1.24, 95%CI: 0.82–1.86, I2 = 85%). Two types of cohort studies were studied in this study. Prospective research included 4 studies [19, 34, 40, 45] that showed statistical significance (OR = 1.82, 95%CI: 1.04–13.17, I2 = 80%), while retrospective research included 12 studies [31,32,33, 35,36,37,38,39, 41,42,43,44] that showed no statistical significance (OR = 1.30, 95%CI: 0.91–1.85, I2 = 97%).

Table 1 Subgroup analyses of different outcomes
Full size table
Fig. 2
figure 2

Meta-analysis of the association between Chorioamnionitis or Funisitis and lung injury

Full size image

NRDS

Different types of CA or FV on NRDS

Sixty-seven thousand eight hundred thirty-six participants were included in 14 studies; [19, 31,32,33,34,35,36,37,38,39,40, 42, 43, 45] the results (OR = 0.97, 95%CI: 0.67–1.40, I2 = 96%) indicated no statistical significance between infants exposed to CA or FV and the incidence of NRDS (Table 2). Separate meta-analyses were also conducted for CA (HCA and CCA), FV and HCA with FV. The results indicated that neither CA (OR = 0.87, 95%CI: 0.57–1.33, I2 = 97%) nor FV (OR = 1.23, 95%CI: 0.48–3.15, I2 = 90%), nor HCA with FV (OR = 1.85, 95%CI: 0.15–22.63, I2 = 68%) were statistically significant. Furthermore, no statistically significant difference was observed between those exposed to CCA and those who were not (OR = 1.86, 95%CI: 0.93–3.72, I2 = 97%). Based on the data (OR = 0.72, 95%CI: 0.57–0.90, I2 = 72%), exposure to HCA was associated with a reduction in NRDS incidence among preterm infants, with 7 studies [35,36,37, 40, 42, 43, 45] from developing countries showing statistically significant results (OR = 0.64, 95%CI: 0.55–0.75, I2 = 36%), while 4 studies [19, 31, 34, 38] from developed countries were not (OR = 0.9, 95%CI: 0.57–1.42, I2 = 82%).

Table 2 Subgroup analyses ofa NRDS
Full size table

Different stages of HCA on NRDS

The viewpoints of HCA for NRDS that early protection, late damage were showed in some studies. We further assembled the data on different stages of HCA for lung injury [19, 36, 42]. When further stratified by grade of HCA, HCA (II) is significantly related to decrease incidence of NRDS (HCA (II): OR = 0.48, 95%CI: 0.35–0.65, I2 = 0%), as well as HCA (I and II) (OR = 0.54, 95%CI: 0.39–0.76, I2 = 57%). However, the results (HCA (I): OR = 0.58, 95%CI: 0.31–1.11, I2 = 78%; HCA (III): OR = 1.27, 95%CI: 0.64–2.50, I2 = 64%) showed that HCA (I) and HCA (III) has no obvious protective against NRDS.

Gestational age

As preterm infants < 32 weeks of gestation are in the late tubule or cystic stage, we compared the relationship between HCA and NRDS at < 32 weeks and ≥ 32 weeks (Fig. 3). The results (OR = 0.63, 95%CI: 0.48–0.82, I2 = 71%) suggested that exposure to HCA for infants under 32 weeks [19, 31, 35, 40, 42, 43, 45] significantly decreased the incidence of NRDS, but there was no significant difference between infants ≥ 32 weeks [34, 36, 37] (OR = 1.05, 95%CI: 0.57–1.94, I2 = 81%).

Fig. 3
figure 3

Meta-analysis of the association between HCA and NRDS in premature infants of different gestational ages

Full size image

BPD

Different diagnose of BPD

The definition of BPD has also evolved as research on BPD has progressed. One was diagnosed with oxygen dependency at 36-wk postmenstrual age, and another was diagnosed with dependency on oxygen supplementation at a corrected age of 28 d. We examined whether preterm infants exposed to CA or FV would be at a higher risk of developing BPD in light of the two different definitions of BPD. From the data: A positive association was be found between exposure to CA or FV and BPD28 (OR = 3.83, 95%CI: 2.33–6.3, I2 = 90%), and the association remained significant for CA or FV and BPD36 (OR = 1.94, 95%CI: 1.16–3.25, I2 = 66%).

Different types of CA or FV on BPD

Based on the results shown in Table 3, there is a positive relationship between CA or FV and BPD (OR = 3.21, 95%CI: 2.1–4.93, I2 = 92%) regardless of whether infants are exposed to CA (OR = 3.18, 95%CI: 1.68–6.03, I2 = 93%) or FV (OR = 6.36, 95%CI: 2.45–16.52) and whether they are born in developed countries (OR = 3.39, 95%CI: 1.83–6.27, I2 = 96%) or in developing countries (OR = 2.99, 95%CI: 2.11–4.23, I2 = 0%). The prevalence of BPD is significantly associated with infants exposed to HCA (OR = 2.70, 95%CI: 2.38–3.07, I2 = 0%), but not with infants exposed to CCA (OR = 2.77, 95%CI: 0.68–11.21, I2 = 99%).

Table 3 Subgroup analyses of aBPD
Full size table

Different severity degrees of BPD

BPD is classified as mild, moderate, severe, and moderate or severe. As a result of the data collected, we concluded that infants exposed to HCA have an increased risk of developing moderate to severe BPD (OR = 25.38, 95%CI: 7.13–90.32), whereas no obvious meaningful link has been demonstrated between HCA and mild BPD (OR = 2.29, 95%CI: 0.99–5.31). And no research has been conducted on moderate and severe BPD.

High-quality studies

Additional file 3 summarizes the quality of each study according to the Newcastle–Ottawa Scale. Out of a possible nine points, studies received a quality score of 6 points (2 studies), 7 points (9 studies), or 8 points (5 studies). In total, we obtained 14 high-quality studies (at least 7 points) [19, 31,32,33,34,35,36,37, 39,40,41,42, 44], and the results showed statistical significance (OR = 1.49, 95%CI: 1.09–2.03, I2 = 96%) (Table 1).

Publication bias

Publication bias of visual inspection of funnel plots, concentrated and symmetrical, is reported in Fig. 4. Neither the Begg’s test (P > 0.05) nor visual inspection of funnel plots indicated publication or selection bias. There were insufficient studies with different stages of HCA for NRDS and different severity degrees of BPD to evaluate publication bias.

Fig. 4
figure 4

Funnel plot of Publication bias of visual inspection

Full size image

Discussion

In the 1990s, Watterberg et al. [46] first discovered that intrauterine infection had a protective effect on NRDS. In some subsequent studies, the same effect was observed [47, 48], which were attributed the effect to inflammation promoting the generation of PS and fetal lung maturation [38, 49,50,51]. Ding Ran et al. [42] found that in the HCA-exposed group, NRDS incidence was only 25.5%, significantly lower than 45.9% in the control group, consistent with previous findings. Despite the fact that many animal experiments and clinical studies have demonstrated that intrauterine inflammation has a potential protective effect against the occurrence of NRDS, this view has not been unanimously recognized. Gisslen et al. [52] found that the increase in interleukin-6 in cord blood could not reduce the incidence of NRDS in infants. Some studies also found that intrauterine infection could not [18, 20, 51,52,53].

In our meta-analysis, we found no correlation between CA/FV (CA, FV, CA with FV and CCA) and NRDS, but HCA could reduce NRDS risk and is more likely to occur in preterm infants less than 32 weeks of gestation. The protective effect exists in developing countries, but not in developed countries, which may be related with their economic situation, medical development level, living environment, etc. A possible explanation for the protective effect may be that, during intrauterine infection, saturation phosphatidylcholine and surfactant active protein B (SP-B), which regulate lung tension and maintain the physiological state of the lungs, are produced at higher levels. Moreover, some studies have shown that inflammation increases levels of interleukin-6 in fetal peripheral blood, which in turn triggers the production of SP-A in the alveolar epithelium and ultimately increases the production of PS [18, 50, 51]. Additionally, premature infants under 32 weeks of gestation are in the late tubule or cystic stage, with less PS production itself and little protective effect on the fetal lungs, while the role of promoting fetal lung maturation through intrauterine inflammation is more obvious. Furthermore, it is debatable whether severe HCA increases or decreases the incidence of NRDS. Some scholars believe that fetal lung maturity can only be promoted if inflammation is not severe, and severe inflammation can damage fetal lung tissue. Severe inflammation may increase vascular permeability in fetal lungs, leading to PS inactivation as serum proteins leak into alveoli [54,55,56]. Our findings indicate that infants exposed to HCA (I) and (II) had a reduced incidence of NRDS, referred to as a “protective effect”, while HCA (III) was not associated with NRDS. This is somewhat different from the Waterberg hypothesis “early-protection, late-damage effect”. We could not exclude the bias that may caused by the data provided by only 3 studies. For different grade of NRDS, no study provided relevant data.

A recent meta-analysis of studies involving 13,583 infants demonstrated that histological, as opposed to clinical chorioamnitis, was associated with a higher incidence of BPD [23]. The association was no longer significant after accounting for the lack of unpublished studies showing an association and the potential publication bias, including gestational age and birth weight [23]. ELGAN [57] reported no association between HCA and BPD, although 51% of placental cultures obtained from 1,119 extremely premature births produced positive results. Nor was a relationship between placental signs of cellular inflammation and BPD observed in the Alabama preterm birth study, although umbilical blood cultures positive for ureaplasma urealyticum or Mycoplasma hominis more than tripled the risk of BPD (26.8% vs. 10.1%, p = 0.0001) [58, 59]. However, in multivariate analysis, this association was not strong (OR 1.99, 95%CI 0.91–4.37) [59]. We find that CA/FV increased the incidence of BPD, regardless of the diagnosis of BPD (BPD28, BPD36). In addition, HCA was associated with BPD, while CCA was not. This may be due to the fact that only two studies provide data on CCA and BPD. There is no data available on the different stages of HCA and BPD. Upon categorizing BPD, only moderate to severe BPD was related to CA, while the other grades were not. Bias may be caused by insufficient data. Otherwise, the inclusion criteria of this study were CA as the exposure factor and BPD or absence of BPD in preterm neonates as the outcome. And some regression studies were excluded: the outcome had been BPD in preterm infants, and the risk factors were retrospectively traced back. Because we were unable to obtain data from these studies on preterm infants exposed to CA who did not develop BPD, controls could not be performed. Moreover, some studies cannot exclude the influence of other factors such as gestational hypertension, diabetes and other complications on the occurrence of BPD in preterm infants. Therefore, we only included cohort studies with higher levels of evidence to reduce the bias. This is one of the different points of inclusion criteria in the study published in 2019 by Villamor-Martinez et al. [22], that one of the meta-analyses of related studies.

In their study published in 2012, Hartling et al. [21] only discussed the relationship between CA and BPD based on English literature. Although the data revealed a significant correlation between CA and BPD (OR 1.89, 95%CI 1.56–2.3), there was still a substantial amount of bias. CA is not explicitly acknowledged as a BPD risk factor. In the literature published by Sarno et al. [23] in 2021, we found that the inclusion criteria for chorionicamnitis were HCA, excluding CCA, and the data showed that there was no statistical correlation between HCA and NRDS (RR 0.93, 95%CI 1.08–1.67). Nevertheless, it was positively correlated with BPD (RR 1.75, 95%CI 1.37–2.23). After excluding the effect of preterm birth, it was found that HCA could reduce the incidence of NRDS (RR 0.57, CI 95% 0.35–0.93), but had no statistical significance with BPD (RR 0.99, CI 0.76–1.3). Preterm infants were not analyzed separately in this study. And the incidence of BPD and NRDS was not significantly correlated with HCA or FV. Villamor-Martinez et al. [22] published in 2019 confirmed that exposure to CA is associated with a higher risk of developing BPD among preterm infants, but this association may also be modulated by gestational age and risk of NRDS.

Compared to the previous systematic review [21,22,23], this study includes a substantial update; the term funisitis has been included in our search strategy; detailed grading of exposures and outcomes has been performed; and multiple risk factors for BPD and NRDS have been excluded from the study. With the advancement of science, the definition of CA/BPD/NRDS has become more precise. In order to avoid the bias caused by different definitions, we excluded studies where explicit definitions were not provided and selected literature based on the same definition, instead of the time line, which differed from Sarno et al. [23]. Moreover, at present, there is no systematic review about this subject in China, on this basis, our study on the relationship between CA and lung injury in preterm infants compares the differences between developed and developing countries. There are some limitations in this study. First, the data collection is not comprehensive and lacks unpublished literature, which may result in the omission of some positive or negative results, thereby introducing bias into the meta-analysis. Additionally, the number of studies on the relationship between different stages of HCA and different degrees of lung injury in preterm infants is limited, which may affect the bias of the meta-analysis results the number of studies on the relationship between different stage of HCA and different degree lung injury in preterm infants is small, which may affect the bias of the meta-analysis results. Due to limited conditions, our study on the relationship between CA and lung injury in preterm infants did not compares the differences among ethnic groups, environmental factors, and genetic factors. Finally, this study does not assess whether the effect of CA on lung injury in premature infants was gender-specific because of the paucity of pertinent data.

Conclusions

Overall, the current evidence suggests that CA or FV appears to be associated with a higher incidence of lung injury in preterm infants, particularly in developed countries. And HCA can increase the incidence of BPD but reduce the incidence of NRDS. We agree with the viewpoint of ‘early protection’, however, we disagree with ‘late damage’, which requires further clinical research and observation. In addition, the results of this study indicate that this “protective effect” only applies to infants under 32 weeks of age. Furthermore, the incidence of BPD can also be increased by HCA, highlighting the importance of improving the attention of clinical workers to premature infants and requesting NICU consultation as soon as possible after birth in order to initiate early intervention and guide a later diagnosis and treatment for such premature infants. What’s more, a further study is necessary to clarify the role of CA in the severity of lung injury in preterm infants and to exclude the effect of gestational age itself on lung injury.

Availability of data and materials

All data generated or analyzed during this study are included in this article and its online supplementary material. Further inquiries can be directed to the corresponding author.

Abbreviations

CA:

Chorioamnionitis

HCA:

Histological chorioamnionitis

CCA:

Clinical chorioamnionitis

FV:

Funisitis

NRDS:

Neonatal respiratory distress syndrome

BPD:

Bronchopulmonary dysplasia

References

  1. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015;213(4 Suppl):S29-52. https://doi.org/10.1016/j.ajog.2015.08.040.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Li L, Zhu D W, Chen JK, Liu D. Placental chorioamnionitis and fetal prognosis. Obstetrics-Gynecology and Genetics(Electronic Edition). 2018;8(2):50–4.

  3. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, et al. The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol. 2000;183(5):1124–9. https://doi.org/10.1067/mob.2000.109035.

    Article  CAS  PubMed  Google Scholar 

  4. Shan RB. Intrauterine infection and neonatal pulmonary outcomes. Chin Pediatr Emerg Med. 2016;23(5):304–7, 11. https://doi.org/10.3760/cma.j.issn.1673-4912.2016.05.004.

    Article  CAS  Google Scholar 

  5. Cappelletti M, Presicce P, Kallapur S. Immunobiology of acute chorioamnionitis. Front Immunol. 2020;11:649. https://doi.org/10.3389/fimmu.2020.00649.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Woodd SL, Montoya A, Barreix M, Pi L, Calvert C, Rehman AM, et al. Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS Med. 2019;16(12):e1002984. https://doi.org/10.1371/journal.pmed.1002984.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339–54. https://doi.org/10.1016/j.clp.2010.02.003.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Du Plessis AH, van Rooyen DRM, Jardien-Baboo S, Ten Ham-Baloyi W. Screening and diagnosis of women for chorioamnionitis: An integrative literature review. Midwifery. 2022;113:103417. https://doi.org/10.1016/j.midw.2022.103417.

    Article  PubMed  Google Scholar 

  9. Zhu Y. A prospective multicenter epidemiology investigation of premature newborn [D]: Fudan University. 2012. CNKI:CDMD:1.1013.103173.

    Google Scholar 

  10. Fowler JR, Simon LV. Chorioamnionitis. StatPearls. Treasure Island FL: © 2022, StatPearls Publishing LLC.; 2022.

    Google Scholar 

  11. Xie YL, Sun Y, Chen Q, Diao YN, Shan RB. Are chorioamnionitis and funisitis associated with lung injury or pulmonary function of premature infants? Chin J Neonatol. 2018;33(2):109–12. https://doi.org/10.3760/cma.j.issn.2096-2932.2018.02.008.

    Article  Google Scholar 

  12. Been JV, Vanterpool SF, de Rooij JD, Rours GI, Kornelisse RF, van Dongen MC, van Gool CJ, de Krijger RR, Andriessen P, Zimmermann LJ, Kramer BW. A clinical prediction rule for histological chorioamnionitis in preterm newborns. PloS one. 2012;7(10):e46217. https://doi.org/10.1371/journal.pone.0046217.

  13. Wang Y, Lu L, Q, Yang X, Lv J. Effects of minimally invasive pulmonary surfactant on the liver and kidney function, oxygenation and respiratory function of neonatal respiratory distress syndrome. Prog Modern Biomed. 2020;20(16):3138–42. https://doi.org/10.13241/j.cnki.pmb.2020.16.030.

  14. Rocha G, Rodrigues M, Guimarães H. Respiratory distress syndrome of the preterm neonate–placenta and necropsy as witnesses. J Matern Fetal Neonatal Med. 2011;24(1):148–51. https://doi.org/10.3109/14767058.2010.482613.

    Article  PubMed  Google Scholar 

  15. De Luca D, Tingay D, van Kaam A, Courtney S, Kneyber M, Tissieres P, et al. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatr Crit Care Med. 2022;23(7):524–34. https://doi.org/10.1097/pcc.0000000000002961.

    Article  PubMed  Google Scholar 

  16. Zhang J. Progress in the prevention and treatment of neonatal respiratory distress syndrome. Bao Jian Wen Hui. 2021;1:244–5.

    Google Scholar 

  17. Mao XH. Comparison of the efficacy of Curosurf and Calsurf in the treatment of neonatal respiratory distress syndrome. Shanxi Med J. 2020;49(16):2108–10. https://doi.org/10.3969/j.issn.0253-9926.2020.16.007.

    Article  Google Scholar 

  18. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009;12(4):253–74. https://doi.org/10.2350/09-01-0586.1.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Park CW, Park JS, Jun JK, Yoon BH. Mild to moderate, but not minimal or severe, acute histologic chorioamnionitis or intra-amniotic inflammation is associated with a decrease in respiratory distress syndrome of preterm newborns without fetal growth restriction. Neonatology. 2015;108(2):115–23. https://doi.org/10.1159/000430766.

    Article  CAS  PubMed  Google Scholar 

  20. Verlato G, Simonato M, Giambelluca S, Fantinato M, Correani A, Cavicchiolo ME, et al. Surfactant components and tracheal aspirate inflammatory markers in preterm infants with respiratory distress syndrome. J Pediatr. 2018;203:442–6. https://doi.org/10.1016/j.jpeds.2018.08.019.

    Article  PubMed  Google Scholar 

  21. Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2012;97(1):F8–17. https://doi.org/10.1136/adc.2010.210187.

    Article  PubMed  Google Scholar 

  22. Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT, Degraeuwe P, Zimmermann LJI, Kramer BW, et al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants: a systematic review, meta-analysis, and metaregression. JAMA Netw Open. 2019;2(11):e1914611. https://doi.org/10.1001/jamanetworkopen.2019.14611.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Sarno L, Della Corte L, Saccone G, Sirico A, Raimondi F, Zullo F, et al. Histological chorioamnionitis and risk of pulmonary complications in preterm births: a systematic review and Meta-analysis. J Matern Fetal Neonatal Med. 2021;34(22):3803–12. https://doi.org/10.1080/14767058.2019.1689945.

    Article  PubMed  Google Scholar 

  24. Doyle L, Cheong J, Hay S, Manley B, Halliday H. Early (>7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;10(10):CD001146. https://doi.org/10.1002/14651858.CD001146.pub6.

    Article  PubMed  Google Scholar 

  25. Higgins JPT TJ. Cochrane handbook for systematic reviews of interventions: The Cochrane Collaboration. 2022

  26. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed). 2009;339:b2535. https://doi.org/10.1136/bmj.b2535.

    Article  PubMed  Google Scholar 

  27. Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16(5):428-39. https://doi.org/10.1097/PCC.0000000000000350.

  28. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–9. https://doi.org/10.1164/ajrccm.163.7.2011060.

    Article  CAS  PubMed  Google Scholar 

  29. Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler MA, et al. Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698–713. https://doi.org/10.5858/arpa.2015-0225-CC.

    Article  PubMed  Google Scholar 

  30. Cota GF, de Sousa MR, Fereguetti TO, Rabello A. Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS Negl Trop Dis. 2013;7(5):e2195. https://doi.org/10.1371/journal.pntd.0002195.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005;22(3):155–9. https://doi.org/10.1055/s-2005-865020.

    Article  CAS  PubMed  Google Scholar 

  32. Soraisham AS, Singhal N, McMillan DD, Sauve RS, Lee SK, Canadian Neonatal N. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol. 2009;200(4):372 e1-6. https://doi.org/10.1016/j.ajog.2008.11.034.

    Article  PubMed  Google Scholar 

  33. Lee J, Oh KJ, Park CW, Park JS, Jun JK, Yoon BH. The presence of funisitis is associated with a decreased risk for the development of neonatal respiratory distress syndrome. Placenta. 2011;32(3):235–40. https://doi.org/10.1016/j.placenta.2010.11.006.

    Article  CAS  PubMed  Google Scholar 

  34. Tsiartas P, Kacerovsky M, Musilova I, Hornychova H, Cobo T, Savman K, et al. The association between histological chorioamnionitis, funisitis and neonatal outcome in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2013;26(13):1332–6. https://doi.org/10.3109/14767058.2013.784741.

    Article  PubMed  Google Scholar 

  35. Zhang L, Zhou T, Zou Z, H., Yang B, Y. The relationship between histological chorioamnionitis,fetal vasculitis and the morbidity of neonatal respira-tory distress syndrome. Chin Pediatr Emerg Med. 2015;22(7):482–5. https://doi.org/10.3760/cma.j.issn.1673-4912.2015.07.009.

  36. Cai Z, Y, Liu J, D, Bian H, L, Cai J, L, Pan J. The effect of histologic chorioamnionitis on the incidence of respiratory distress syndrome in premature infants. Chin J Neonatol. 2016;31(6):446–9. https://doi.org/10.3969/j.issn.1673-6710.2016.06.011.

  37. Li TT. Histologic chorioamnionitis and Related maternal and neonatal complications [D]: Southern Medical University. 2016. https://doi.org/10.7666/d.Y3117191.

    Book  Google Scholar 

  38. Miyazaki K, Furuhashi M, Ishikawa K, Tamakoshi K, Hayashi K, Kai A, et al. Impact of chorioamnionitis on short- and long-term outcomes in very low birth weight preterm infants: the Neonatal Research Network Japan. J Matern Fetal Neonatal Med. 2016;29(2):331–7. https://doi.org/10.3109/14767058.2014.1000852.

    Article  PubMed  Google Scholar 

  39. Metcalfe A, Lisonkova S, Sabr Y, Stritzke A, Joseph KS. Neonatal respiratory morbidity following exposure to chorioamnionitis. BMC Pediatr. 2017;17(1):128. https://doi.org/10.1186/s12887-017-0878-9.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Xie YL. The study on pulmonary injury and common diseases of premature infants exposed to chorioamnionitis and funisitis [D]: Qingdao University. 2017.

    Google Scholar 

  41. Zhang LX. Correlation between histological chorioamnionitis and bronchopulmonary dysplasia in preterm infants aged<34 weeks [D]: Qingdao University; 2020. https://doi.org/10.3760/cma.j.issn.2096-2932.2020.03.006.

  42. Ding R, Chen Q, Zhang QW, Sun QB, Wang DJ, Shan RB. Association of different stages of histological chorioamnionitis with respiratory distress syndrome in preterm infants with a gestational age of < 32 weeks. Chin J Contemp Pediatr. 2021;23(3):248–53. https://doi.org/10.7499/j.issn.1008-8830.2011088.

    Article  Google Scholar 

  43. Fang X. Study on the Effect of Histological Chorioamnionitis on the Outcome of Premature Infants<34 Weeks [D]: Xi’an Medical University. 2021.

    Google Scholar 

  44. Zhang HJ, Fan L, Guo AL, Liu XY, Yuan XR. Correlation between bronchopulmonary dysplasia and intrauterine infection in preterm infants. Chin J Woman Child Health Res. 2022;33(1):29–37.

  45. Zhang K, N, Zhang C, Y. Correlation of histological chorioamnionitis with respiratory distress syndrome in preterm infants <34 weeks. Acta Academiae Medicinae Weifang. 2022;44(1):38–41.

  46. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97(2):210–5.

    Article  CAS  PubMed  Google Scholar 

  47. Been JV, Zimmermann LJ. Histological chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94(3):F218–25. https://doi.org/10.1136/adc.2008.150458.

    Article  CAS  PubMed  Google Scholar 

  48. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med. 2009;14(1):2–7. https://doi.org/10.1016/j.siny.2008.08.011.

    Article  PubMed  Google Scholar 

  49. Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol. 2012;39(3):441–57. https://doi.org/10.1016/j.clp.2012.06.010.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Lee SM, Kim BJ, Park JS, Norwitz ER, Oh JW, Oh S, et al. Risk of intra-amniotic infection/inflammation and respiratory distress syndrome according to the birth order in twin preterm neonates. J Matern Fetal Neonatal Med. 2020;33(9):1566–71. https://doi.org/10.1080/14767058.2018.1523890.

    Article  PubMed  Google Scholar 

  51. Ryan E, Eves D, Menon PJ, Alnafisee S, Mooney EE, Downey P, et al. Histological chorioamnionitis is predicted by early infant C-reactive protein in preterm infants and correlates with neonatal outcomes. Acta paediatrica (Oslo, Norway : 1992). 2020;109(4):720–7. https://doi.org/10.1111/apa.15038.

    Article  CAS  PubMed  Google Scholar 

  52. Gisslen T, Alvarez M, Wells C, Soo MT, Lambers DS, Knox CL, et al. Fetal inflammation associated with minimal acute morbidity in moderate/late preterm infants. Arch Dis Child Fetal Neonatal Ed. 2016;101(6):F513–9. https://doi.org/10.1136/archdischild-2015-308518.

    Article  PubMed  Google Scholar 

  53. Lee Y, Kim HJ, Choi SJ, Oh SY, Kim JS, Roh CR, et al. Is there a stepwise increase in neonatal morbidities according to histological stage (or grade) of acute chorioamnionitis and funisitis?: effect of gestational age at delivery. J Perinat Med. 2015;43(2):259–67. https://doi.org/10.1515/jpm-2014-0035.

    Article  PubMed  Google Scholar 

  54. Jobe AH. “Miracle” extremely low birth weight neonates: examples of developmental plasticity. Obstet Gynecol. 2010;116(5):1184–90. https://doi.org/10.1097/AOG.0b013e3181f60b1d.

    Article  PubMed  Google Scholar 

  55. Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology. 2011;99(4):316–9. https://doi.org/10.1159/000326619.

    Article  CAS  PubMed  Google Scholar 

  56. Seehase M, Collins JJ, Kuypers E, Jellema RK, Ophelders DR, Ospina OL, et al. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. PLoS ONE. 2012;7(10):e47631. https://doi.org/10.1371/journal.pone.0047631.

    Article  ADS  CAS  PubMed Central  PubMed  Google Scholar 

  57. Bose C, Van Marter LJ, Laughon M, O’Shea TM, Allred EN, Karna P, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics. 2009;124(3):e450–8. https://doi.org/10.1542/peds.2008-3249.

    Article  PubMed  Google Scholar 

  58. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195(3):803–8. https://doi.org/10.1016/j.ajog.2006.06.083.

    Article  CAS  PubMed  Google Scholar 

  59. Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol. 2008;198(1):43 e1-5. https://doi.org/10.1016/j.ajog.2007.07.033.

    Article  PubMed  Google Scholar 

Download references

Funding

There was no funding relating to this review.

Author information

Authors and Affiliations

  1. Department of Neonatology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, China

    Wen-li Liu, Xu-feng Yin, Feng-xia Zhou & Shao-jun Chen

  2. Department of Surgery, School of Medicine, Jianghan University, Wuhan, Hubei, China

    Yao Zhou

  3. Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China

    Chao Zhang

  4. Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, 442008, Hubei, China

    Jun Chen

Authors
  1. Wen-li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yao Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xu-feng Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng-xia Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shao-jun Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SJC and WLL had full access to all of the data in the study, and took responsibility for the integrity of the data and the accuracy of the data analysis. SJC, JC and CZ designed the study. CZ and XFY developed and tested the data collection forms. WLL and FXZ acquired the data. WLL and YZ conducted the analysis and interpreted the data. WLL drafted the manuscript. All authors critically revised the manuscript. All authors reviewed the manuscript.

Corresponding authors

Correspondence to Chao Zhang or Shao-jun Chen.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Wl., Zhou, Y., Zhang, C. et al. Relationship between chorioamnionitis or funisitis and lung injury among preterm infants: meta-analysis involved 16 observational studies with 68,397 participants. BMC Pediatr 24, 157 (2024). https://doi.org/10.1186/s12887-024-04626-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-024-04626-0

Keywords

BMC Pediatrics

ISSN: 1471-2431

Contact us